SEC Form 4 · accession 0001209191-18-025627
AMICUS THERAPEUTICS, INC. · FOLD
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Hung Do
Officer — Chief Science Officer
Period of report
Apr 17, 2018
Accepted (ET)
Apr 19, 2018 · 6:03 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001178879
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Apr 17, 2018 | S | 50,000 | $15.00 | D | 446,771 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1The sale of common stock was made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 5, 2018.